New directions in the treatment of infected pleural effusion

Clinical Radiology

Volumn 61, Issue 9, 2006, Pages 719-722

  Rahman, N M ^a   Gleeson, F V ^b  

^a Departments of Respiratory Medicine

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DEOXYRIBONUCLEASE; FIBRINOLYTIC AGENT; GLUCOSE; LACTATE DEHYDROGENASE; LACTIC ACID; PLACEBO; STREPTOKINASE;

ADJUVANT THERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; FIBRIN DEPOSITION; FIBRINOLYTIC THERAPY; HUMAN; INFLAMMATION; LUNG PARENCHYMA; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PLEURA CAVITY; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURA FLUID; PLEURISY; PLEURODESIS; PRIORITY JOURNAL; REVIEW; THERAPY RESISTANCE; THORACOTOMY; THORAX DRAINAGE; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

BACTERIAL INFECTIONS; CHEST TUBES; DRAINAGE; HUMANS; PLEURAL EFFUSION; THORACOTOMY; THROMBOLYTIC THERAPY;

EID: 33746892682     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2006.05.004     Document Type: Review

References (41)

1. Miller Jr. J.I. The history of surgery of empyema, thoracoplasty, Eloesser flap, and muscle flap transposition. Chest Surg Clin N Am 10 (2000) 45-53 viii
2. Peters R.M. Empyema thoracis: historical perspective. Ann Thorac Surg 48 (1989) 306-308
3. Himelman R.B., and Callen P.W. The prognostic value of loculations in parapneumonic pleural effusions. Chest 90 (1986) 852-856
4. Huang H.C., Chang H.Y., Chen C.W., et al. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema. Chest 115 (1999) 751-756
5. Noppen M., De Waele M., Li R., et al. Volume and cellular content of normal pleural fluid in humans examined by pleural lavage. Am J Respir Crit Care Med 162 (2000) 1023-1026
6. Rahman NM, Batt S, Gleeson FV, et al. The relationship between lung parenchymal CT appearances and pleural bacteriology in pleural infection. American Thoracic Society Conference 2006.
7. Broaddus V.C., Hebert C.A., Vitangcol R.V., et al. Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am Rev Respir Dis 146 (1992) 825-830
8. Kroegel C., and Antony V.B. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 10 (1997) 2411-2418
9. Pothula V., and Krellenstein D.J. Early aggressive surgical management of parapneumonic empyemas. Chest 105 (1994) 832-836
10. Dajczman E., Gordon A., Kreisman H., et al. Long-term postthoracotomy pain. Chest 99 (1991) 270-274
11. Tillett W.S., Sherry S., and Read C.T. The use of streptokinase-streptodornase in the treatment of postneumonic empyema. J Thorac Surg 21 (1951) 275-297
12. Davies C.W., Gleeson F.V., and Davies R.J. BTS guidelines for the management of pleural infection. Thorax 58 Suppl. 2 (2003) ii18-ii28
13. Bouros D., Schiza S., Patsourakis G., et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med 155 (1997) 291-295
14. Bouros D., Schiza S., Tzanakis N., et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 159 (1999) 37-42
15. Davies R.J., Traill Z.C., and Gleeson F.V. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 52 (1997) 416-421
16. Diacon A.H., Theron J., Schuurmans M.M., et al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 170 (2004) 49-53
17. Tuncozgur B., Ustunsoy H., Sivrikoz M.C., et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract 55 (2001) 658-660
18. Cameron R., and Davies H.R. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev (2004) CD002312
19. Maskell N.A., Davies C.W., Nunn A.J., et al. UK cntrolled trial of intrapleural streptokinase for pleural infection. N Engl J Med 352 (2005) 865-874
20. Light R.W., Nguyen T., Mulligan M.E., et al. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung 178 (2000) 13-18
21. Simpson G., Roomes D., and Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 117 (2000) 1728-1733
22. Simpson G., Roomes D., and Reeves B. Successful treatment of empyema thoracis with human recombinant deoxyribonuclease. Thorax 58 (2003) 365-366
23. Miller K.S., and Sahn S.A. Chest tubes. Indications, technique, management and complications. Chest 91 (1987) 258-264
24. Light R.W. Management of parapneumonic effusions. Arch Intern Med 141 (1981) 1339-1341
25. Gobien R.P., Stanley J.H., Schabel S.I., et al. The effect of drainage tube size on adequacy of percutaneous abscess drainage. Cardiovasc Intervent Radiol 8 (1985) 100-102
26. Rothlin M.A., Schob O., Klotz H., et al. Percutaneous drainage of abdominal abscesses: are large-bore catheters necessary?. Eur J Surg 164 (1998) 419-424
27. Fox V., Gould D., Davies N., et al. Patients' experiences of having an underwater seal chest drain: a replication study. J Clin Nurs 8 (1999) 684-692
28. Antunes G., Neville E., Duffy J., et al. BTS guidelines for the management of malignant pleural effusions. Thorax 58 Suppl. 2 (2003) ii29-ii38
29. Clementsen P., Evald T., Grode G., et al. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir Med 92 (1998) 593-596
30. Davies C.W., Kearney S.E., Gleeson F.V., et al. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 160 (1999) 1682-1687
31. LeMense G.P., Strange C., and Sahn S.A. Empyema thoracis. Therapeutic management and outcome. Chest 107 (1995) 1532-1537
32. Melloni G., Carretta A., Ciriaco P., et al. Decortication for chronic parapneumonic empyema: results of a prospective study. World J Surg 28 (2004) 488-493
33. Sendt W., Forster E., and Hau T. Early thoracoscopic debridement and drainage as definite treatment for pleural empyema. Eur J Surg 161 (1995) 73-76
34. Brutsche M.H., Tassi G.F., Gyorik S., et al. Treatment of sonographically stratified multiloculated thoracic empyema by medical thoracoscopy. Chest 128 (2005) 3303-3309
35. Ridley P.D., and Braimbridge M.V. Thoracoscopic debridement and pleural irrigation in the management of empyema thoracis. Ann Thorac Surg 51 (1991) 461-464
36. Striffeler H., Gugger M., Im H., et al. Video-assisted thoracoscopic surgery for fibrinopurulent pleural empyema in 67 patients. Ann Thorac Surg 65 (1998) 319-323
37. Kim B.Y., Oh B.S., Jang W.C., et al. Video-assisted thoracoscopic decortication for management of postpneumonic pleural empyema. Am J Surg 188 (2004) 321-324
38. Luh S.P., Chou M.C., Wang L.S., et al. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients. Chest 127 (2005) 1427-1432
39. Waller D.A. Thoracoscopy in management of postpneumonic pleural infections. Curr Opin Pulm Med 8 (2002) 323-326
40. Wait M.A., Sharma S., Hohn J., et al. A randomized trial of empyema therapy. Chest 111 (1997) 1548-1551
41. Coote N. Surgical versus non-surgical management of pleural empyema. Cochrane Database Syst Rev (2002) CD001956